Subscribe to our Newsletters !!

    Kumar Jeetendra

    Medovate announces new agreement with Mercury Medical® securing 100% distributor coverage for SAFIRA™ in the USA

    Cambridge, UK – 15 December 2020 –Medovate is proud to announce conclusion of an agreement with Mercury Medical to distribute its medical device SAFIRA™ (SAFer Injection for Regional Anesthesia) – a move that will now provide 100% coverage across the United States of America. Despite the ongoing global COVID-19 pandemic which has closed many country

    New information shows empowering results for patients with neuro-degenerative blinding eye illness

    New data published in the Journal Science Translational Medicine shows encouraging results in a worldwide clinical trial for patients diagnosed with the neuro-degenerative blinding eye disease; Leber Hereditary Optic Neuropathy (LHON. The disease is an inherited type of vision loss estimated to affect 1 in 30,000 to 50,000 individuals. LHON most often afflicts individuals with

    INTEGRA Biosciences’ VIAFLO electronic pipettes

    Preparation of qPCR plates is a repetitive, time-consuming task when done manually, and having the right pipettes makes all the difference. Postdoctoral researcher Daisy Shu explained: “After graduating in optometry, I moved into research, studying cataracts – clouding of the lens – for my PhD at the University of Sydney before taking up my present

    Sygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilities

    Nottingham and Alderley Park, UK – 16th December 2020 – Life Science Newswire – Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical contract research organization, is strengthening its high-throughput screening (HTS) and translational oncology service-offerings by investing £3 million in new instrumentation and equipment. Sygnature’s Translational Oncology department at Alderley Park is currently

    Skin may assist with foreseeing future heart issues

    Our skin informs us when we have spent too much time in sunlight or when the dry air of winter has sucked away too much moisture. Now Jefferson researchers find that the skin may also foretell problems unrelated to the protective barrier. An international group of researchers headed by Jouni Uitto, MD, PhD, a Professor

    New study reveals Chlorhexidine mouthwash kills 99.9% of SARS CoV2 virus in 30 seconds

    Hyderabad, 17th December, 2020: A preliminary laboratory based research conducted by Dr. HSJ Institute of Dental Sciences, Panjab University in collaboration with CSIR-Institute of Microbial Technology (IMTECH) revealed that one of the most routinely used mouth rinses, Chlorhexidine, has proven to be effective against SARS CoV2. The study, titled “Chlorhexidine: An effective anti-Covid mouth rinse”

    European Society for Medical Oncology (ESMO) clinical practice guidelines recommend scalp cooling to prevent chemotherapy-induced alopecia

    Huddersfield, UK – 17 December 2020 – The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, has updated the Clinical Practice Guidelines for Dermatological Toxicities Related to Anticancer Agents to include the recommendation of scalp cooling for the prevention of chemotherapy-induced alopecia (CIA) as a Category IIB recommendation. A multidisciplinary

    Heparan Sulfate Products for COVID-19 Infection, Disease & Therapeutics Research

    AMSBIO offer a wide range of Heparan Sulfate antibodies, enzymes, standards and ready-to-use Heparanase activity assays for researchers seeking to better understand COVID-19 and thereby to combat the pandemic. Heparan Sulfate (HS) is increasingly recognised as a key factor in infection by the SARS-CoV-2 virus, which is the cause of the current COVID-19 Coronavirus pandemic.